Government panel recommends retaining doorstep delivery of medicines

A government sub-committee has recommended retaining the 2020 notification permitting doorstep delivery of medicines, instead of withdrawing it as sought by chemists. The panel has instead suggested stricter enforcement to prevent online sale without valid prescriptions and ensure compliance with the notification. The recommendation would preserve the existing legal route for doorstep delivery while increasing compliance expectations for pharmacies and digital platforms, particularly around prescription verification and sale procedures.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.